Thanks for the verbatim update- yep it’s an ongoing struggle for all of us. In respect of NMPA process do we think the company runs a risk of its IP being poached & the approval doesn’t materialise? That’s why I have asked the Dr a number of times as to whether the market could be progressively updated as “audit milestones” are ticked off. I am always given a prompt & courteous email reply but no answer to my direct question unfortunately. I cannot fathom why these processes cannot be communicated to the market to provide confidence (restore confidence)
- Forums
- ASX - By Stock
- GMV
- GMV The Future
GMV The Future, page-837
-
- There are more pages in this discussion • 2,177 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online